Growth Metrics

Nutex Health (NUTX) Convertible Debt (2016 - 2022)

Nutex Health (NUTX) has disclosed Convertible Debt for 8 consecutive years, with $5400.0 as the latest value for Q4 2022.

  • For Q4 2022, Convertible Debt fell 99.91% year-over-year to $5400.0; the TTM value through Dec 2022 reached $5400.0, down 99.91%, while the annual FY2022 figure was $5400.0, 99.91% down from the prior year.
  • Convertible Debt hit $5400.0 in Q4 2022 for Nutex Health, down from $6.0 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $6.0 million in Q4 2021 and bottomed at $5400.0 in Q4 2022.
  • Average Convertible Debt over 5 years is $1.1 million, with a median of $409287.0 recorded in 2018.
  • Year-over-year, Convertible Debt skyrocketed 13769.44% in 2018 and then crashed 99.91% in 2022.
  • Nutex Health's Convertible Debt stood at $299996.0 in 2018, then increased by 9.55% to $328652.0 in 2019, then decreased by 29.9% to $230399.0 in 2020, then skyrocketed by 2504.18% to $6.0 million in 2021, then plummeted by 99.91% to $5400.0 in 2022.
  • According to Business Quant data, Convertible Debt over the past three periods came in at $5400.0, $6.0 million, and $230399.0 for Q4 2022, Q4 2021, and Q1 2020 respectively.